-
Preparing for the revisions to the EU’s pharmaceutical legislation – what we know now
25 Apr 2024 10:12 GMT
… to the revised EU pharmaceutical legislation introduced in April … of developing new treatments, pharmaceutical manufacturers have serious concerns on … example, if a small biotech is working on a high … (the biggest concern for biotechs) and providing some level …
-
Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting
25 Apr 2024 11:00 GMT
… , Barcelona, Spain.
About Purple Biotech Purple Biotech Ltd. (NASDAQ/TASE … successfully develop and commercialize our pharmaceutical products; the expense, length, … any other applicable regulator of pharmaceutical products; the regulatory environment …
-
Petri Dish: Vertex scales cell manufacturing; German biotech enters Mass.
25 Apr 2024 09:28 GMT
… rare move for a growing biotech, but it is newsworthy. This … week saw a German biotech announce its expansion to Greater … . Then, Boston’s own Vertex Pharmaceuticals looked internationally to sign a …
-
Walgreens To Launch $24 Billion Business Dedicated To Specialty Pharmacy
25 Apr 2024 08:00 GMT
… specialty revenue, Walgreens Specialty Pharmacy is the largest independent provider … on specialty pharmacy that draws thousands of pharmacy, specialty pharmacy and pharmaceutical industry … on the market derived from biotechnology. Such medicines are more …
-
Portland biotech Sparrow Pharmaceuticals raises $10M to further clinical trials
24 Apr 2024 22:08 GMT
-
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
24 Apr 2024 20:05 GMT
ROCKVILLE, Md., April 24, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced …
-
Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
24 Apr 2024 20:01 GMT
BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today announced …
-
[Podcast] Partner for Progress: Strategies for Biotech Success
24 Apr 2024 19:18 GMT
In this three-part podcast series, hear from seasoned experts from Allucent as they discuss a range of topics, including how small and mid-sized companies can take a more strategic approach to pharmacovigilance, a regulatory & development roadmap for …
-
BigHat Biosciences Partners with Janssen Biotech to Guide Antibody Discovery & Design
24 Apr 2024 16:00 GMT
Breaking News
Collaboration will combine the drug discovery, clinical development and data science expertise from Johnson & Johnson with BigHat’s AI/ML platform.
04.24.24
BigHat Biosciences, a biotechnology company with an artificial intelligence…
-
Drug and biotech companies join lobbying push on China bill as scrutiny of WuXi continues
24 Apr 2024 16:08 GMT
Almost 20 biopharma and life sciences companies have registered to lobby on a bill that could ban US companies from working with Chinese life sciences contractors, according to federal records.
Since the Biosecure Act was introduced …